TNC and prostate cancer: This suggests that TNC expression in an osteogenic niche may be selective for CRPC evolution by regulating both alternative splicing and selectively stabilizing AR-V7 protein in disseminated prostate cancer cells, and AR-V7 positive cancer cells further modulates the tumor niche by regulating autocrine TNC expression.